FDA.reportPublic FDA data

NATRIUM PHOSPHORICUM 6X

Manufacturer
Seroyal USA | SAN’UP
Effective date
2021-07-14
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 02:14:40

Label at a glance#

ProductNATRIUM PHOSPHORICUM 6X
Active ingredientSODIUM PHOSPHATE
Label structure12 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients

Natrum Phosphoricum (Sodium Phosphate) 6X

OTC - PURPOSE SECTION

Uses
For the temporary relief of symptoms associated with mild indigestion.

WARNINGS SECTION

Warnings
Do not use if you ever had an allergic
reaction to this product or any of its
ingredients.
Stop use and ask a doctor if symptoms
persist or worsen.
If pregnant or breastfeeding, ask a
health professional before use.

Keep out of reach of children. In case of
overdose, get medical help or contact a
Poison Control Center right away

OTC - PREGNANCY OR BREAST FEEDING SECTION

If you are pregnant or breastfeeding, ask a healthcare practitioner before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

OTC - ASK DOCTOR SECTION

Stop use and ask a doctor if symptoms persist or worsen.

INACTIVE INGREDIENT SECTION

Inactive ingredients
Lactose monohydrate (milk), magnesium
stearate, sodium carboxymethylcellulose,
xylitol

DOSAGE & ADMINISTRATION SECTION

Directions
Tip bottle slightly allowing for tablets to fall into the cap.
Use cap to drop tablets into mouth and allow them to dissolve under the tongue.

Adults and adolescents (12 years and older)

Take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner.

Children (under 12 years)

Take under the direction of your healthcare practitioner.

INDICATIONS & USAGE SECTION

Uses
For the temporary relief of symptoms
associated with mild indigestion.

Directions
Tip bottle slightly allowing for tablets to fall into the cap.
Use cap to drop tablets into mouth and allow them to dissolve under the tongue.

Adults and adolescents (12 years and older)

Take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner.

Children (under 12 years)

Take under the direction of your healthcare practitioner.

OTHER SAFETY INFORMATION

Do not use if seal is missing or
broken.
Store in a cool, dry place.
Contents may not fill package in order
to accommodate required labeling.
Please rely on stated quantity.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

62106-1059-262106-1059-2

NDC 62106-1059-2

UNDA
tissue salt
NATRIUM PHOSPHORICUM 6X
Homeopathic Remedy
Schuessler salt

For the temporary relief of symptoms associated with mild indigestion

100 Tablets

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
4b7700e3-6e0e-45e5-9d22-6f754d61386eProduct name220250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62106-1059-2NATRIUM PHOSPHORICUM 6X100 in 1 BOTTLE, GLASSTABLET1005
62106-1059-2NATRIUM PHOSPHORICUM 6X1 in 1 CARTONTABLET15

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62106-1059NATRIUM PHOSPHORICUM 6X (SODIUM PHOSPHATE) TABLET [SEROYAL USA]5Current NDC, Legacy NDC, 2 package rows20210715_22cc1c1e-626f-4a15-e054-00144ff88e88.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SODIUM PHOSPHATEACTIVE INGREDIENTSE337SVY371
PHOSPHATE IONACTIVE MOIETYNK08V8K8HR1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH481
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5X1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I301
XYLITOLINACTIVE INGREDIENTVCQ006KQ1E1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62106-105962106-1059-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
SODIUM PHOSPHATESE337SVY37ACTIB
LACTOSE MONOHYDRATEEWQ57Q8I5XIACT
XYLITOLVCQ006KQ1EIACT
CROSCARMELLOSE SODIUMM28OL1HH48IACT
MAGNESIUM STEARATE70097M6I30IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 10 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ETABLET / ORAL15.04 mgExact identifier — unii+dosage form
4 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESPRAY / SUBLINGUAL22 mgExact identifier — unii+route
4 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET / SUBLINGUAL10 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESPRAY / SUBLINGUAL22 mgExact identifier — unii+route
4 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET / SUBLINGUAL505 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET / SUBLINGUAL10 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ETABLET / ORAL15.04 mgExact identifier — unii+dosage form
4 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET / SUBLINGUAL505 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NATRIUM PHOSPHORICUM 6XSODIUM PHOSPHATESeroyal USA22cc1c1e-626f-4a15-e054-00144ff88e882021-07-14WarningsExact identifier
ndc (package): 62106-1059-2
ndc (product): 62106-1059
ndc11 (package): 62106105902
spl id: c71d7cd0-09ad-bb0b-e053-2995a90ac703
spl set id: 22cc1c1e-626f-4a15-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.